Results 11 to 20 of about 10,443 (221)

Neutrophil-reactive autoantibodies in blood donors: Can we expect TRALI? [PDF]

open access: yesTransfusion
Abstract Background Transfusion‐related acute lung injury (TRALI) is a clinical condition characterized by acute non‐cardiogenic pulmonary edema during or after transfusion. Despite several mitigation strategies, TRALI remains a leading cause of transfusion‐related deaths.
Jehle S   +7 more
europepmc   +2 more sources

Novel method for trend change detection and hypothesis generation in hemovigilance: A transfusion-related immunomodulation and blood production changes study. [PDF]

open access: yesTransfusion
Abstract Background Immunomodulatory consequences of transfusion, known as transfusion‐related immune modulation (TRIM), impact patients but are not captured by hemovigilance systems. This study's objective is to explore TRIM impacts of production changes made by the blood supplier. Methods We included all transfused and non‐transfused adult inpatients
Ning S   +15 more
europepmc   +2 more sources

Adverse events associated with use of immunoglobulin in pediatric patients reported to the US Food and Drug Administration Adverse Event Reporting System, 2001-2023. [PDF]

open access: yesPediatr Allergy Immunol
Abstract Background Immunoglobulin products are widely used for the treatment of immunodeficiency and autoimmune disorders. Although clinical trials have demonstrated their efficacy and tolerability, data describing their postmarketing safety profile in pediatric populations remain limited, particularly regarding rare and serious adverse events.
Wei S   +4 more
europepmc   +2 more sources

Tirofiban interferes with antibody-mediated transfusion-related acute lung injury by inhibiting platelet-neutrophil binding

open access: yesZhongguo shuxue zazhi, 2022
Objective To explore the feasibility of tirofiban, a platelet surface glycoprotein (GP)Ⅱb/Ⅲa receptor antagonist intervene in transfusion-related acute lung injury (TRALI), by inhibiting platelet activation and by preventing platelet and neutrophil ...
Xin YUAN   +6 more
doaj   +1 more source

Pulmonary disease as a risk factor for transfusion-related acute lung injury

open access: yesERJ Open Research, 2021
Transfusion-related acute lung injury (TRALI) is a severe condition characterised by noncardiogenic pulmonary oedema that develops within 6 h of blood transfusion.
Akira Yokoyama   +9 more
doaj   +1 more source

Study on the protective effect of rapamycin-treated dendritic cells on transfusion-related acute lung injury after infection

open access: yesZhongguo shuxue zazhi, 2022
Objective To investigate the viability of rapamycin-treated rapamycin-treated dendritic cells (DCs) in intervening transfusion-related acute lung injury (TRALI) after infection.
Li GAO   +6 more
doaj   +1 more source

Mechanism and intervention of murine transfusion-related acute lung injury caused by anti-CD36 antibodies

open access: yesJCI Insight, 2023
Anti-CD36 Abs have been suggested to induce transfusion-related acute lung injury (TRALI) upon blood transfusion, particularly in Asian populations. However, little is known about the pathological mechanism of anti-CD36 Ab–mediated TRALI, and potential ...
Da-Wei Chen   +17 more
doaj   +1 more source

Blood product transfusion in emergency department patients: A case-control study of practice patterns and impact on outcome [PDF]

open access: yes, 2017
Definitions of comorbid conditions.
Beyer, Alexander   +4 more
core   +5 more sources

Severe antibody‐mediated transfusion‐related acute lung injury in an obstetric patient following transfusion of fresh frozen plasma from a non‐transfused male blood donor

open access: yesClinical Case Reports, 2021
Transfusion‐Related Acute Lung Injury (TRALI) has been associated with neutrophil reacting antibodies in transfused blood products. We report a case of life‐threatening TRALI in an obstetric patient triggered by transfusion from a non‐transfused male ...
Charlotte Nielsen Agergaard   +5 more
doaj   +1 more source

Leucoreduction of blood components. an effective way to increase blood safety? [PDF]

open access: yes, 2015
Over the past 30 years, it has been demonstrated that removal of white blood cells from blood components is effective in preventing some adverse reactions such as febrile non-haemolytic transfusion reactions, immunisation against human leucocyte antigens
Bianchi, Maria   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy